The Gu laboratory studies how pancreatic islet beta cells are
made and how they function and survive over a long life-span using
mouse and human islet models. The impact of these studies is to
reveal how beta cells in some individuals will lose function and
viability, resulting in reduced functional beta-cell mass and
subsequent diabetes in human subjects.
Four major islet cell types reside in the islets. They are
alpha, beta, delta, and PP cells that secrete glucagon, insulin,
somatostatin, and pancreatic polypeptide, respectively.
Dysfunction of endocrine islets, especially the insulin secreting
beta cells, results in diabetes. Paradoxically, insulin secretion
per se makes beta cells vulnerable to workload-induced death and
dysfunction, presumably via over-activation of stress response
genes (SRGs). Our goals are to unravel the molecular and cellular
mechanisms that allow the generation and maintenance of sufficient
functional beta-cell mass in each individual to prevent the
development of diabetes.
Our current studies focus on:
- Establishing how genetic and epigenetic factors pre-determine
postnatal functional β-cell mass and the risk of diabetes. It is
well established that several metabolic diseases, including
diabetes, is greatly influenced by the maternal environments, best
known as “Developmental Origin of Health and Disease – DOHaD”. We
have shown that modulating the DNA enhancer methylation patterns in
islet progenitors can impact the proliferation and secretion
capacity of postnatal beta cells. Our follow-up studies are to
define the specific epigenetic modifications that predetermine
postnatal beta-cell fitness (i.e., the ability to enhance their
proliferation and secretion under stimulation).
- Determining how β-cells selectively repress failure-causing
SRGs. For sustainable function, each β cell has to synthesize
millions of proinsulin molecules in the ER, with ~20% of these
misfolded in the ER, which cause ER stress and dysfunction. High
glucose metabolism, the trigger of insulin secretion, will induce
overproduction of reactive oxygen species (ROS) that cause
beta-cell dysfunction. Thus, beta cells activate stress responses
to remove misfolded proteins and ROS. However, the SRGs cannot be
overactivated, which would have caused cell dysfunction and/or
death. We have shown that a family of transcription factors,
(Myelin transcription factors or Myt TFs) guards against SRG
overactivation. Our current studies is test if eliminating the Myt
TF protection predisposes human β cells to workload-induced failure
and diabetes.
- Determining the mechanisms and physiological roles of MT
regulation in β cells. Microtubules (MTs) are tubulin-assembled
biopolymers that act as a high way for long-range vesicular
transport. Thus, the conventional view is that the β cells use MTs
growing out of the centrosome to transport insulin vesicles from
the cell interior to underneath the plasma membrane for docking and
secretion. In contrast, we recently showed that the beta-cell MTs
form a non-directional meshwork that is unsuitable for directional
cargo transport, but they act as a “trap” for insulin vesicles to
present over secretion. Our current studies for this topic is to
examine the molecular players that can regulate MT activities and
how MT-deregulation causes β-cell failure and diabetes. He and his
collaborator are actively examining the roles of several motor
proteins, including kinesins and dyneins, and microtubule
associated proteins (MAPS) in this process.
Publications
Featured publications
- Glucose Regulates Microtubule Disassembly and the Dose of Insulin Secretion via Tau Phosphorylation. Ho KH, Yang X, Osipovich AB, Cabrera O, Hayashi ML, Magnuson MA, Gu G, Kaverina I (2020) Diabetes 69(9): 1936-1947
› Primary publication · 32540877 (PubMed) · PMC7458041 (PubMed Central) - Myt Transcription Factors Prevent Stress-Response Gene Overactivation to Enable Postnatal Pancreatic β Cell Proliferation, Function, and Survival. Hu R, Walker E, Huang C, Xu Y, Weng C, Erickson GE, Coldren A, Yang X, Brissova M, Kaverina I, Balamurugan AN, Wright CVE, Li Y, Stein R, Gu G (2020) Dev Cell 53(4): 390-405.e10
› Primary publication · 32359405 (PubMed) · PMC7278035 (PubMed Central) - Coregulator Sin3a Promotes Postnatal Murine β-Cell Fitness by Regulating Genes in Ca Homeostasis, Cell Survival, Vesicle Biosynthesis, Glucose Metabolism, and Stress Response. Yang X, Graff SM, Heiser CN, Ho KH, Chen B, Simmons AJ, Southard-Smith AN, David G, Jacobson DA, Kaverina I, Wright CVE, Lau KS, Gu G (2020) Diabetes 69(6): 1219-1231
› Primary publication · 32245798 (PubMed) · PMC7243292 (PubMed Central) - Neurog3-Independent Methylation Is the Earliest Detectable Mark Distinguishing Pancreatic Progenitor Identity. Liu J, Banerjee A, Herring CA, Attalla J, Hu R, Xu Y, Shao Q, Simmons AJ, Dadi PK, Wang S, Jacobson DA, Liu B, Hodges E, Lau KS, Gu G (2019) Dev Cell 48(1): 49-63.e7
› Primary publication · 30620902 (PubMed) · PMC6327977 (PubMed Central) - Quantitative assessment of cell population diversity in single-cell landscapes. Liu Q, Herring CA, Sheng Q, Ping J, Simmons AJ, Chen B, Banerjee A, Li W, Gu G, Coffey RJ, Shyr Y, Lau KS (2018) PLoS Biol 16(10): e2006687
› Primary publication · 30346945 (PubMed) · PMC6211764 (PubMed Central) - Synaptotagmin 4 Regulates Pancreatic β Cell Maturation by Modulating the Ca Sensitivity of Insulin Secretion Vesicles. Huang C, Walker EM, Dadi PK, Hu R, Xu Y, Zhang W, Sanavia T, Mun J, Liu J, Nair GG, Tan HYA, Wang S, Magnuson MA, Stoeckert CJ, Hebrok M, Gannon M, Han W, Stein R, Jacobson DA, Gu G (2018) Dev Cell 45(3): 347-361.e5
› Primary publication · 29656931 (PubMed) · PMC5962294 (PubMed Central) - Microtubules Negatively Regulate Insulin Secretion in Pancreatic β Cells. Zhu X, Hu R, Brissova M, Stein RW, Powers AC, Gu G, Kaverina I (2015) Dev Cell 34(6): 656-68
› Primary publication · 26418295 (PubMed) · PMC4594944 (PubMed Central)